RT Journal Article
SR Electronic
A1 Sinclair, Heather Q.
T1 ARB Therapy in the Setting of Paroxysmal AF: Results from the ANTIPAF Trial
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 8
SP 16
OP 16
DO 10.1177/155989771008013
UL http://mdc.sagepub.com/content/10/8/16.abstract
AB Olmesartan does not reduce the incidence of atrial fibrillation (AF) episodes among patients with paroxysmal AF without structural heart disease, according to findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation [ANTIPAF; NCT0098137] trial.